Officials of SMS Pharmaceuticals will host a plant visit for analysts and investors on February 26, 2025, at the Vizianagaram plant in Andhra Pradesh. Participating firms include Valcore Capital Advisors, InCred Asset Management, Valentis Advisors, Nuvama Wealth, and PCS Securities Ltd. The visit will feature management discussions focusing on industry and company developments that are already publicly available, ensuring no confidential information is disclosed. This initiative provides an opportunity for increased transparency and engagement with key stakeholders, potentially enhancing investor confidence and offering insights into the company’s operations and strategy.